|
 M.D. Anderson Cancer Center has been a founding partner in cancer assay development and continues to conduct clinical trials and validation of Nuvera’s diagnostic tests.
 Nuvera has formed a partnership with Veridex, LLC, a Johnson and Johnson company, to commercialize and market diagnostic tests in breast cancer response to therapy.
 Nuvera has received several grants from National Cancer Institute to collaborate and develop diagnostic assays in cancer therapy response.
 Nuvera has received several SBIR/STTR grants under the US Department of Defense to develop bioinformatics approaches and molecular analytics for medical applications.
 Nuvera has partnered with Tufts University to study and develop metabolite-based diagnostic assays that help predict general fitness, endurance, and fatigue in healthy individuals.
Nuvera collaborates actively with leading cancer centers worldwide to study, develop, and validate diagnostic approaches in cancer therapy response.
|
